BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Diabetes. Nov 15, 2026; 17(11): 124123
Published online Nov 15, 2026. doi: 10.4239/wjd.124123
Table 1 Association between diabetic status and cancer prevalence
CaseModel 1
Model 2
Model 3
OR
95%CI
P value
OR
95%CI
P value
OR
95%CI
P value
1NHANESPrediabetes1.661.48-1.86< 0.0011.261.12-1.41< 0.0011.250.99-1.590.068
Diabetes2.462.16-2.81< 0.0011.591.36-1.85< 0.0011.641.18-2.280.004
2CHARLSPrediabetes0.950.77-1.170.6320.850.67-1.080.1791.690.98-2.890.057
Diabetes1.791.58-2.03< 0.0011.651.44-1.89< 0.0012.001.11-3.590.020
Table 2 Association between diabetic status and survival in patients with cancer from the National Health and Nutrition Examination Survey
CaseModel 1
Model 2
Model 3
HR
95%CI
P value
HR
95%CI
P value
HR
95%CI
P value
Prediabetes0.930.78-1.100.3870.890.75-1.060.1870.910.76-1.090.312
Diabetes1.371.15-1.63< 0.0011.281.07-1.530.0071.251.03-1.510.023
Table 3 Mendelian randomization analysis of the causal association between diabetes and cancer
Diabetes (exposure)
Cancer (outcome)
Method
Single nucleotide polymorphisms
P value
OR (95%CI)
P value for pleiotropy
finn-b-E4_DMNASukb-e-2453_CSAIVW80.0121.50 (1.09, 2.06)0.685
Weighted median8< 0.0011.57 (1.21, 2.05)
Simple mode80.0491.76 (1.10, 2.81)
Weighted mode80.0091.59 (1.23, 2.04)
MR Egger80.1211.65 (0.96, 2.82)


Write to the Help Desk